Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of feeding behavior. [GOC:obol]
Positive regulation of feeding behavior is a complex biological process that involves a intricate interplay of neuronal circuits, hormonal signals, and metabolic cues. It encompasses the mechanisms that enhance or promote the initiation, maintenance, and termination of food intake. Key aspects include:
1. **Hunger Signals:**
* **Ghrelin:** A hormone produced in the stomach, ghrelin acts as a potent appetite stimulant, triggering signals in the brain that increase hunger. It is released when the stomach is empty, promoting food seeking behavior.
* **Leptin:** Secreted by adipose (fat) tissue, leptin acts as a satiety hormone, suppressing appetite and promoting energy expenditure. High levels of leptin signal satiety, reducing food intake.
2. **Brain Centers and Neural Pathways:**
* **Hypothalamus:** A key brain region involved in regulating hunger and satiety, the hypothalamus houses several nuclei that respond to various signals related to energy balance.
* **Arcuate Nucleus:** This region contains neurons that produce neuropeptides like neuropeptide Y (NPY), which stimulates appetite, and pro-opiomelanocortin (POMC), which suppresses appetite.
* **Lateral Hypothalamus:** This area promotes feeding behavior and is activated by hunger signals.
* **Ventromedial Hypothalamus:** This region promotes satiety and is activated by signals of fullness.
* **Reward System:** Food consumption activates the brain's reward system, leading to pleasurable sensations that reinforce eating behavior. This involves neurotransmitters like dopamine, which plays a role in motivation and pleasure.
3. **Metabolic Signals:**
* **Blood Glucose Levels:** Low blood glucose levels stimulate hunger and activate pathways that promote food intake.
* **Insulin:** This hormone, released by the pancreas, helps regulate blood glucose levels and also plays a role in suppressing appetite.
* **Gut Hormones:** Hormones produced in the gastrointestinal tract, such as cholecystokinin (CCK) and peptide YY (PYY), signal satiety and reduce food intake.
4. **Environmental Factors:**
* **Sensory Input:** Sight, smell, and taste of food can trigger appetite and influence food choices.
* **Social Cues:** Social interactions and cultural influences can influence eating behavior.
* **Stress:** Stress can lead to increased appetite, particularly for comfort foods.
The balance of these various signals determines the overall regulation of feeding behavior. Positive regulation of feeding behavior ensures that the body receives adequate nutrition, while also preventing overeating and maintaining energy balance.'
"
Protein | Definition | Taxonomy |
---|---|---|
Nuclear receptor subfamily 4 group A member 3 | A nuclear receptor subfamily 4 group A member 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q92570] | Homo sapiens (human) |
Melanocyte-stimulating hormone receptor | A melanocyte-stimulating hormone receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q01726] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
melanotan-ii | melanotan-II: synthetic cyclic heptapeptide, an analog of alpha-melanotropin (4,10); capable of stimulating melanin synthesis & promoting rapid tanning of skin; currently in trials for use in the prevention of sunlight-induced skin cancer | organic molecular entity | |
bms-470539 | BMS-470539: a selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice; structure in first source | ||
bremelanotide | bremelanotide: a synthetic peptide analogue of alpha-MSH, is an agonist at melanocortin receptors including the MC3R and MC4R, which are expressed primarily in the central nervous system; | oligopeptide | |
acetyl-histidyl-phenylalanyl-arginyl-tryptophanamide | |||
ac-his-dphe-arg-trp-nh2 | |||
rm-493 | setmelanotide: an anti-obesity agent | ||
alpha-msh | peptide hormone | anti-inflammatory agent | |
msh, 4-nle-7-phe-alpha- | polypeptide | dermatologic drug | |
pci 32765 | ibrutinib : A member of the class of acrylamides that is (3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine in which the piperidine nitrogen is replaced by an acryloyl group. A selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase, it is used for treatment of B-cell malignancies. ibrutinib: a Btk protein inhibitor | acrylamides; aromatic amine; aromatic ether; N-acylpiperidine; pyrazolopyrimidine; tertiary carboxamide | antineoplastic agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |